Wu Yun, Li Hongru, Yu Xiaoli, Lin Ming, Chen Yusheng
Department of Respiratory Medicine, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, Fujian 350001, People's Republic of China.
Onco Targets Ther. 2020 Dec 2;13:12421-12426. doi: 10.2147/OTT.S276627. eCollection 2020.
Lymphangioleiomyomatosis (LAM) is a rare disease affecting young women, which occurs sporadically or in patients with tuberous sclerosis complex (TSC). The main manifestations of TSC in the kidney include cysts and angiomyolipoma (AML). Although renal cell carcinoma (RCC) is not a manifestation of TSC, it has a 2-4% incidence in TSC patients. Furthermore, LAM is rare in patients with RCC. Herein, we present a case of a 40-year-old woman with LAM and RCC in the right kidney. We checked for mutations in the and genes from both blood and kidney lesions and found a heterozygous mutation of c.1717-30G> A in intron 16 of gene. In TSC patients, the diagnosis of RCC is challenging because the cancer is rare, and it is often difficult to distinguish it from AML with conventional imaging techniques. Therefore, it is recommended that patients with TSC undergo renal imaging follow-ups annually for kidney masses.
淋巴管平滑肌瘤病(LAM)是一种影响年轻女性的罕见疾病,可散发发生或见于结节性硬化症(TSC)患者。TSC在肾脏的主要表现包括囊肿和血管平滑肌脂肪瘤(AML)。虽然肾细胞癌(RCC)并非TSC的表现,但在TSC患者中的发病率为2% - 4%。此外,LAM在RCC患者中也很罕见。在此,我们报告一例40岁女性,右肾同时患有LAM和RCC。我们检测了血液和肾脏病变中 和 基因的突变,发现 基因第16内含子存在c.1717 - 30G>A杂合突变。在TSC患者中,RCC的诊断具有挑战性,因为这种癌症很罕见,而且用传统成像技术往往难以将其与AML区分开来。因此,建议TSC患者每年进行肾脏影像学检查以监测肾脏肿块。